LBX Pharmacy has disclosed a dual incentive plan consisting of restricted stock and an employee stock ownership plan, setting high growth targets requiring net profit in 2027 and 2028 to increase by no less than 75 percent and 100 percent respectively, based on the 2025 net profit. The company plans to grant a total of 14.337 million shares to over 340 incentive recipients, with vesting conditions tied to substantial net profit growth, corresponding to a net profit of 946 million yuan in 2027 and 1.081 billion yuan in 2028. At the same time, the company has launched a share buyback program of 40 million to 80 million yuan, with a repurchase price not exceeding 18.08 yuan per share, and the repurchased shares will be used for the employee stock ownership plan and equity incentives. Boosted by this news, LBX Pharmacy's share price hit the daily limit up on August 11, closing at 14.01 yuan per share, with a total market capitalization exceeding 10.6 billion yuan.
Laobaixing PharmacyEquity incentive plan and buyback signal confidence, with high growth targets.
